This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Mayer - Rokitansky - Küster - Hauser (MRKH) syndrome

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome is characterized by congenital agenesis of vagina, a rudimentary uterus and normal fallopian tubes and ovaries
  • the definitive risk of benign and malignant neoplasms development in uterine remnants and ovaries in patients with MRKH syndrome is still unknown
  • there have been case reports of ovarian cancer, endodermal sinus tumor of the ovary and immature teratoma that have been associated with MRKH
  • a case report of a dysgerminoma associated with MRKH has been described (1)

Reference:

  1. Mishina A et al. Ovarian dysgerminoma in Mayer-Rokitansky-Kuster-Hauser syndrome. Eur J Obstet Gynecol Reprod Biol. 2007 Mar;131(1):105-6.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.